NR4A3 and neoplasm: We found that PRDM1/NR4A3 double KO significantly increased the absolute numbers of CAR T-cells in the tumor (P < 0.05) and peripheral blood (P < 0.001) compared to AAVS1 KO CAR T-cells fig.